Evaluation of tumor growth in the tibia of RANKL-deficient mice revealed a decrease in growth rates, that was most prominent 10 days after injection of osteosarcoma cells, and these mice also developed fewer metastatic lesions in the lungs in comparison with wild type mice [67]. The gene discussed is TNFSF11; the disease is osteosarcoma.